Novo Nordisk
Robin Evers has a strong background in Regulatory Affairs and currently holds a position as a Non Executive Board Member at Orexo AB publ. Prior to that, they served as Senior Vice President of Submissions & Life Cycle Management at Novo Nordisk. They have also held leadership positions at Pfizer and Wyeth Pharmaceuticals. Robin Evers holds a Bachelor of Science in Molecular Biology from the University of Portmouth.
Novo Nordisk
377 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.